DE69626034T2 - Zusammensetzung für verbesserung der pankreasfunktion - Google Patents

Zusammensetzung für verbesserung der pankreasfunktion

Info

Publication number
DE69626034T2
DE69626034T2 DE69626034T DE69626034T DE69626034T2 DE 69626034 T2 DE69626034 T2 DE 69626034T2 DE 69626034 T DE69626034 T DE 69626034T DE 69626034 T DE69626034 T DE 69626034T DE 69626034 T2 DE69626034 T2 DE 69626034T2
Authority
DE
Germany
Prior art keywords
composition
cells
pancreas function
improving pancreas
improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69626034T
Other languages
English (en)
Other versions
DE69626034D1 (de
Inventor
Itaru Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69626034D1 publication Critical patent/DE69626034D1/de
Application granted granted Critical
Publication of DE69626034T2 publication Critical patent/DE69626034T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE69626034T 1995-11-09 1996-11-08 Zusammensetzung für verbesserung der pankreasfunktion Expired - Lifetime DE69626034T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29123895 1995-11-09
PCT/JP1996/003277 WO1997017086A2 (en) 1995-11-09 1996-11-08 Composition for improving pancreatic function

Publications (2)

Publication Number Publication Date
DE69626034D1 DE69626034D1 (de) 2003-03-06
DE69626034T2 true DE69626034T2 (de) 2003-08-14

Family

ID=17766273

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626034T Expired - Lifetime DE69626034T2 (de) 1995-11-09 1996-11-08 Zusammensetzung für verbesserung der pankreasfunktion

Country Status (8)

Country Link
US (1) US6232288B1 (de)
EP (1) EP0862451B1 (de)
CN (1) CN1202112A (de)
AT (1) ATE231727T1 (de)
AU (1) AU7506396A (de)
CA (1) CA2233009C (de)
DE (1) DE69626034T2 (de)
WO (1) WO1997017086A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1125584A4 (de) * 1998-10-30 2005-01-12 Takeda Chemical Industries Ltd Betacellulin protein-enthaltende präparationen
ATE368111T1 (de) 1998-12-09 2007-08-15 Takeda Pharmaceutical Betacellulin-veränderung
AU2005201435A1 (en) * 1999-04-06 2005-04-28 Genentech, Inc. Use of ErbB receptor ligands in treating diabetes
DE60039160D1 (de) * 1999-04-06 2008-07-24 Genentech Inc Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
US20020099008A1 (en) 1999-04-26 2002-07-25 Daniel R. Twardzik Method for stimulating hematopoiesis using tgf-alpha
JP2002543096A (ja) * 1999-04-26 2002-12-17 ステム セル ファーマシューティカルズ，インコーポレーテッド ＴＧＦ−αポリペプチド、機能性断片およびそれらの利用法
US20020193301A1 (en) 1999-08-19 2002-12-19 Stem Cell Pharmaceuticals, Inc. TGF-alpha polypeptides, functional fragments and methods of use therefor
US6815418B2 (en) * 1999-08-19 2004-11-09 Kaleidos Pharma, Inc. TGF-α polypeptides, functional fragments and methods of use therefor
US6677307B2 (en) 1999-08-19 2004-01-13 Kaleidos Pharma, Inc. TGF-α polypeptides, functional fragments and methods of use therefor
US20020077291A1 (en) * 2000-09-22 2002-06-20 Alan Upshall Method of treatment of tumors using transforming growth factor-alpha
WO2002079457A1 (en) * 2001-03-29 2002-10-10 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
CN100516204C (zh) * 2001-04-24 2009-07-22 味之素株式会社 干细胞及其分离方法
US20040132679A1 (en) * 2002-09-03 2004-07-08 Baylor College Of Medicine Induction of pancreatic islet formation
JPWO2004091661A1 (ja) * 2003-04-15 2006-07-06 中外製薬株式会社 糖尿病治療剤
TWI323125B (en) 2004-04-16 2010-04-01 Hon Hai Prec Ind Co Ltd An method for auto-adjusting the focus of the digital camera
EP1855726A2 (de) * 2005-02-03 2007-11-21 Biotech Institute For International Innovation Inc. Zusammensetzungen und verfahren zur therapeutischen behandlung von diabetes
KR20070063574A (ko) 2005-05-17 2007-06-19 모리나가 뉴교 가부시키가이샤 췌장 기능 개선을 위한 의약 또는 음식품
JP4065016B2 (ja) 2005-05-17 2008-03-19 森永乳業株式会社 膵臓機能改善のための医薬又は飲食品
KR100866274B1 (ko) 2005-05-17 2008-11-03 모리나가 뉴교 가부시키가이샤 췌장 기능 개선을 위한 의약 또는 음식품
EP1890722A2 (de) * 2005-05-27 2008-02-27 Five Prime Therapeutics, Inc. Verfahren und zusammensetzungen für die stimulation der glucoseaufnahme in muskelzellen, und behandlung von krankheiten
US20080145937A1 (en) * 2006-09-22 2008-06-19 Baylor Research Institute In Vivo Transformation of Pancreatic Acinar Cells into Insulin-Producing Cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0555785B1 (de) 1992-02-10 1996-12-04 Takeda Chemical Industries, Ltd. Mitogen für die glatte Muskulatur und dessen kodierende DNS

Also Published As

Publication number Publication date
WO1997017086A3 (en) 1997-06-19
EP0862451A2 (de) 1998-09-09
WO1997017086A2 (en) 1997-05-15
CA2233009A1 (en) 1997-05-15
EP0862451B1 (de) 2003-01-29
AU7506396A (en) 1997-05-29
DE69626034D1 (de) 2003-03-06
US6232288B1 (en) 2001-05-15
CA2233009C (en) 2005-05-10
ATE231727T1 (de) 2003-02-15
CN1202112A (zh) 1998-12-16

Similar Documents

Publication Publication Date Title
DE69626034T2 (de) Zusammensetzung für verbesserung der pankreasfunktion
DE69534618D1 (de) Verfahren zur herstellung rekombinanter adeno-associated viren (aav) und deren verwendung
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
AU1402788A (en) Vascular anticoagulant proteins
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
ATE186305T1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
FI871288A (fi) Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu
FI971420A (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
PT809437E (pt) Tiois para promover crescimento de celulas progenitoras hematopoieticas
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
BR9105783A (pt) Polipeptidio,processo para o tratamento em vidro de neuronios e composicoes celular e farmaceutica
ATE113982T1 (de) Verzweigungsenzym und dessen verwendung.
DE3784988D1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
DE69728415D1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
IT1230689B (it) Metodo per realizzare mobili, particolarmente poltrone, divani o simili, da fogli di feltro trattati con sostanze indurenti e mobili relativi
DK461887D0 (da) Fremgangsmaade til selektivt at foroege andelen af enkelte hovedkomponenter af antibiotikum a 40926-kompleks
UA26870C2 (uk) Спосіб підвищеhhя продукуваhhя протеїhу с, спосіб підвищеhhя рівhя його модифікації
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
ATE317021T1 (de) Antisense modulierung von lfa-3
DE69916829D1 (de) Genetisch veränderte fibroblasten und ihre verwendung
DE3673686D1 (de) Immobilisierte maltooligosaccharid-bildende amylase und verfahren zur herstellung von maltooligosaccharid unter verwendung des genannten enzyms.
ATE276364T1 (de) Biologisches material zur herstellung pharmazeutischer zusammensetzungen zur behandlung von säugetieren

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP